15-42287751-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP3BP4_StrongBP6_Very_StrongBS1BS2
The NM_198141.3(GANC):c.262G>A(p.Glu88Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00991 in 1,613,020 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0074 ( 8 hom., cov: 32)
Exomes 𝑓: 0.010 ( 106 hom. )
Consequence
GANC
NM_198141.3 missense
NM_198141.3 missense
Scores
7
8
3
Clinical Significance
Conservation
PhyloP100: 6.67
Genes affected
GANC (HGNC:4139): (glucosidase alpha, neutral C) Glycosyl hydrolase enzymes hydrolyse the glycosidic bond between two or more carbohydrates, or between a carbohydrate and a non-carbohydrate moiety. This gene encodes a member of glycosyl hydrolases family 31. This enzyme hydrolyses terminal, non-reducing 1,4-linked alpha-D-glucose residues and releases alpha-D-glucose. This is a key enzyme in glycogen metabolism and its gene localizes to a chromosomal region (15q15) that is associated with susceptibility to diabetes. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
PP3
Multiple lines of computational evidence support a deleterious effect 6: BayesDel_noAF, Cadd, Dann, Eigen, FATHMM_MKL, REVEL [when BayesDel_addAF, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.007130444).
BP6
Variant 15-42287751-G-A is Benign according to our data. Variant chr15-42287751-G-A is described in ClinVar as [Benign]. Clinvar id is 775354.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.0102 (14863/1460886) while in subpopulation MID AF= 0.0189 (109/5762). AF 95% confidence interval is 0.016. There are 106 homozygotes in gnomad4_exome. There are 7523 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GANC | NM_198141.3 | c.262G>A | p.Glu88Lys | missense_variant | 4/24 | ENST00000318010.13 | NP_937784.2 | |
GANC | NM_001393928.1 | c.262G>A | p.Glu88Lys | missense_variant | 5/25 | NP_001380857.1 | ||
GANC | NM_001393929.1 | c.262G>A | p.Glu88Lys | missense_variant | 5/25 | NP_001380858.1 | ||
GANC | NM_001301409.2 | c.262G>A | p.Glu88Lys | missense_variant | 5/12 | NP_001288338.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GANC | ENST00000318010.13 | c.262G>A | p.Glu88Lys | missense_variant | 4/24 | 1 | NM_198141.3 | ENSP00000326227 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00743 AC: 1129AN: 152016Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1129
AN:
152016
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00812 AC: 2037AN: 250902Hom.: 25 AF XY: 0.00859 AC XY: 1165AN XY: 135620
GnomAD3 exomes
AF:
AC:
2037
AN:
250902
Hom.:
AF XY:
AC XY:
1165
AN XY:
135620
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0102 AC: 14863AN: 1460886Hom.: 106 Cov.: 33 AF XY: 0.0104 AC XY: 7523AN XY: 726768
GnomAD4 exome
AF:
AC:
14863
AN:
1460886
Hom.:
Cov.:
33
AF XY:
AC XY:
7523
AN XY:
726768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00740 AC: 1126AN: 152134Hom.: 8 Cov.: 32 AF XY: 0.00677 AC XY: 504AN XY: 74402
GnomAD4 genome
AF:
AC:
1126
AN:
152134
Hom.:
Cov.:
32
AF XY:
AC XY:
504
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
41
ALSPAC
AF:
AC:
43
ESP6500AA
AF:
AC:
8
ESP6500EA
AF:
AC:
77
ExAC
AF:
AC:
1053
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 20, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
D;.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;.;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.76, 0.72
MVP
MPC
0.18
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at